カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のアムロジピン＆オルメサルタン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Amlodipine and Olmesartan Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19121）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19121
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：106
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のアムロジピン＆オルメサルタン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

アムロジピン＆オルメサルタン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のアムロジピン＆オルメサルタンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

アムロジピン＆オルメサルタン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界のアムロジピン＆オルメサルタン市場の主要な市場プレーヤーは以下のとおりです。
・Daiichi Sankyo、Teva、Glenmark Pharmaceuticals、Matrix Laboratories、Torrent Pharmaceuticals、Aurobindo、Macleods Pharmaceuticals、Alembic Pharmaceuticals、Ajanta Pharma、Jubilant Pharma、Accord Healthcare

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、アムロジピン＆オルメサルタン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なアムロジピン＆オルメサルタンメーカーの企業概要、2019年～2022年までのアムロジピン＆オルメサルタンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なアムロジピン＆オルメサルタンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別アムロジピン＆オルメサルタンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのアムロジピン＆オルメサルタンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのアムロジピン＆オルメサルタン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびアムロジピン＆オルメサルタンの産業チェーンを掲載しています。
・第13、14、15章では、アムロジピン＆オルメサルタンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- アムロジピン＆オルメサルタンの概要
- 種類別分析（2017年vs2021年vs2028年）：5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界のアムロジピン＆オルメサルタン市場規模・予測
- 世界のアムロジピン＆オルメサルタン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Daiichi Sankyo、Teva、Glenmark Pharmaceuticals、Matrix Laboratories、Torrent Pharmaceuticals、Aurobindo、Macleods Pharmaceuticals、Alembic Pharmaceuticals、Ajanta Pharma、Jubilant Pharma、Accord Healthcare
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：5/20mg錠、10/20mg錠、5/40mg錠、10/40mg錠
・用途別分析2017年-2028年：病院、ドラッグストア
・アムロジピン＆オルメサルタンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・アムロジピン＆オルメサルタンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・アムロジピン＆オルメサルタンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・アムロジピン＆オルメサルタンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・アムロジピン＆オルメサルタンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Amlodipine and Olmesartan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Amlodipine and Olmesartan market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Amlodipine and Olmesartan global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5/20 mg Tablets segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Amlodipine and Olmesartan include Daiichi Sankyo, Teva, Glenmark Pharmaceuticals, Matrix Laboratories, and Torrent Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Amlodipine and Olmesartan market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5/20 mg Tablets
10/20 mg Tablets
5/40 mg Tablets
10/40 mg Tablets
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Amlodipine and Olmesartan market are listed below:
Daiichi Sankyo
Teva
Glenmark Pharmaceuticals
Matrix Laboratories
Torrent Pharmaceuticals
Aurobindo
Macleods Pharmaceuticals
Alembic Pharmaceuticals
Ajanta Pharma
Jubilant Pharma
Accord Healthcare
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amlodipine and Olmesartan product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Amlodipine and Olmesartan, with price, sales, revenue and global market share of Amlodipine and Olmesartan from 2019 to 2022.
Chapter 3, the Amlodipine and Olmesartan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amlodipine and Olmesartan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Amlodipine and Olmesartan market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Amlodipine and Olmesartan.
Chapter 13, 14, and 15, to describe Amlodipine and Olmesartan sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Amlodipine and Olmesartan Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Amlodipine and Olmesartan Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5/20 mg Tablets
1.2.3 10/20 mg Tablets
1.2.4 5/40 mg Tablets
1.2.5 10/40 mg Tablets
1.3 Market Analysis by Application
1.3.1 Overview: Global Amlodipine and Olmesartan Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Amlodipine and Olmesartan Market Size & Forecast
1.4.1 Global Amlodipine and Olmesartan Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Amlodipine and Olmesartan Sales in Volume (2017-2028)
1.4.3 Global Amlodipine and Olmesartan Price (2017-2028)
1.5 Global Amlodipine and Olmesartan Production Capacity Analysis
1.5.1 Global Amlodipine and Olmesartan Total Production Capacity (2017-2028)
1.5.2 Global Amlodipine and Olmesartan Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Amlodipine and Olmesartan Market Drivers
1.6.2 Amlodipine and Olmesartan Market Restraints
1.6.3 Amlodipine and Olmesartan Trends Analysis
2 Manufacturers Profiles
2.1 Daiichi Sankyo
2.1.1 Daiichi Sankyo Details
2.1.2 Daiichi Sankyo Major Business
2.1.3 Daiichi Sankyo Amlodipine and Olmesartan Product and Services
2.1.4 Daiichi Sankyo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Amlodipine and Olmesartan Product and Services
2.2.4 Teva Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Glenmark Pharmaceuticals
2.3.1 Glenmark Pharmaceuticals Details
2.3.2 Glenmark Pharmaceuticals Major Business
2.3.3 Glenmark Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.3.4 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Matrix Laboratories
2.4.1 Matrix Laboratories Details
2.4.2 Matrix Laboratories Major Business
2.4.3 Matrix Laboratories Amlodipine and Olmesartan Product and Services
2.4.4 Matrix Laboratories Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Torrent Pharmaceuticals
2.5.1 Torrent Pharmaceuticals Details
2.5.2 Torrent Pharmaceuticals Major Business
2.5.3 Torrent Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.5.4 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Aurobindo
2.6.1 Aurobindo Details
2.6.2 Aurobindo Major Business
2.6.3 Aurobindo Amlodipine and Olmesartan Product and Services
2.6.4 Aurobindo Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Macleods Pharmaceuticals
2.7.1 Macleods Pharmaceuticals Details
2.7.2 Macleods Pharmaceuticals Major Business
2.7.3 Macleods Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.7.4 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Alembic Pharmaceuticals
2.8.1 Alembic Pharmaceuticals Details
2.8.2 Alembic Pharmaceuticals Major Business
2.8.3 Alembic Pharmaceuticals Amlodipine and Olmesartan Product and Services
2.8.4 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Ajanta Pharma
2.9.1 Ajanta Pharma Details
2.9.2 Ajanta Pharma Major Business
2.9.3 Ajanta Pharma Amlodipine and Olmesartan Product and Services
2.9.4 Ajanta Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Jubilant Pharma
2.10.1 Jubilant Pharma Details
2.10.2 Jubilant Pharma Major Business
2.10.3 Jubilant Pharma Amlodipine and Olmesartan Product and Services
2.10.4 Jubilant Pharma Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Accord Healthcare
2.11.1 Accord Healthcare Details
2.11.2 Accord Healthcare Major Business
2.11.3 Accord Healthcare Amlodipine and Olmesartan Product and Services
2.11.4 Accord Healthcare Amlodipine and Olmesartan Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Amlodipine and Olmesartan Breakdown Data by Manufacturer
3.1 Global Amlodipine and Olmesartan Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Amlodipine and Olmesartan Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Amlodipine and Olmesartan
3.4 Market Concentration Rate
3.4.1 Top 3 Amlodipine and Olmesartan Manufacturer Market Share in 2021
3.4.2 Top 6 Amlodipine and Olmesartan Manufacturer Market Share in 2021
3.5 Global Amlodipine and Olmesartan Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Amlodipine and Olmesartan Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Amlodipine and Olmesartan Market Size by Region
4.1.1 Global Amlodipine and Olmesartan Sales in Volume by Region (2017-2028)
4.1.2 Global Amlodipine and Olmesartan Revenue by Region (2017-2028)
4.2 North America Amlodipine and Olmesartan Revenue (2017-2028)
4.3 Europe Amlodipine and Olmesartan Revenue (2017-2028)
4.4 Asia-Pacific Amlodipine and Olmesartan Revenue (2017-2028)
4.5 South America Amlodipine and Olmesartan Revenue (2017-2028)
4.6 Middle East and Africa Amlodipine and Olmesartan Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Amlodipine and Olmesartan Sales in Volume by Type (2017-2028)
5.2 Global Amlodipine and Olmesartan Revenue by Type (2017-2028)
5.3 Global Amlodipine and Olmesartan Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Amlodipine and Olmesartan Sales in Volume by Application (2017-2028)
6.2 Global Amlodipine and Olmesartan Revenue by Application (2017-2028)
6.3 Global Amlodipine and Olmesartan Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Amlodipine and Olmesartan Sales by Type (2017-2028)
7.2 North America Amlodipine and Olmesartan Sales by Application (2017-2028)
7.3 North America Amlodipine and Olmesartan Market Size by Country
7.3.1 North America Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
7.3.2 North America Amlodipine and Olmesartan Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Amlodipine and Olmesartan Sales by Type (2017-2028)
8.2 Europe Amlodipine and Olmesartan Sales by Application (2017-2028)
8.3 Europe Amlodipine and Olmesartan Market Size by Country
8.3.1 Europe Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
8.3.2 Europe Amlodipine and Olmesartan Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Amlodipine and Olmesartan Sales by Type (2017-2028)
9.2 Asia-Pacific Amlodipine and Olmesartan Sales by Application (2017-2028)
9.3 Asia-Pacific Amlodipine and Olmesartan Market Size by Region
9.3.1 Asia-Pacific Amlodipine and Olmesartan Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Amlodipine and Olmesartan Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Amlodipine and Olmesartan Sales by Type (2017-2028)
10.2 South America Amlodipine and Olmesartan Sales by Application (2017-2028)
10.3 South America Amlodipine and Olmesartan Market Size by Country
10.3.1 South America Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
10.3.2 South America Amlodipine and Olmesartan Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Amlodipine and Olmesartan Sales by Type (2017-2028)
11.2 Middle East & Africa Amlodipine and Olmesartan Sales by Application (2017-2028)
11.3 Middle East & Africa Amlodipine and Olmesartan Market Size by Country
11.3.1 Middle East & Africa Amlodipine and Olmesartan Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Amlodipine and Olmesartan Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Amlodipine and Olmesartan and Key Manufacturers
12.2 Manufacturing Costs Percentage of Amlodipine and Olmesartan
12.3 Amlodipine and Olmesartan Production Process
12.4 Amlodipine and Olmesartan Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Amlodipine and Olmesartan Typical Distributors
13.3 Amlodipine and Olmesartan Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Amlodipine and Olmesartan Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Amlodipine and Olmesartan Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Major Business
Table 5. Daiichi Sankyo Amlodipine and Olmesartan Product and Services
Table 6. Daiichi Sankyo Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Teva Basic Information, Manufacturing Base and Competitors
Table 8. Teva Major Business
Table 9. Teva Amlodipine and Olmesartan Product and Services
Table 10. Teva Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Glenmark Pharmaceuticals Major Business
Table 13. Glenmark Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 14. Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Matrix Laboratories Basic Information, Manufacturing Base and Competitors
Table 16. Matrix Laboratories Major Business
Table 17. Matrix Laboratories Amlodipine and Olmesartan Product and Services
Table 18. Matrix Laboratories Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Torrent Pharmaceuticals Major Business
Table 21. Torrent Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 22. Torrent Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Aurobindo Basic Information, Manufacturing Base and Competitors
Table 24. Aurobindo Major Business
Table 25. Aurobindo Amlodipine and Olmesartan Product and Services
Table 26. Aurobindo Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Macleods Pharmaceuticals Major Business
Table 29. Macleods Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 30. Macleods Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Alembic Pharmaceuticals Major Business
Table 33. Alembic Pharmaceuticals Amlodipine and Olmesartan Product and Services
Table 34. Alembic Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 36. Ajanta Pharma Major Business
Table 37. Ajanta Pharma Amlodipine and Olmesartan Product and Services
Table 38. Ajanta Pharma Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Jubilant Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Jubilant Pharma Major Business
Table 41. Jubilant Pharma Amlodipine and Olmesartan Product and Services
Table 42. Jubilant Pharma Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 44. Accord Healthcare Major Business
Table 45. Accord Healthcare Amlodipine and Olmesartan Product and Services
Table 46. Accord Healthcare Amlodipine and Olmesartan Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Global Amlodipine and Olmesartan Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 48. Global Amlodipine and Olmesartan Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 49. Market Position of Manufacturers in Amlodipine and Olmesartan, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 50. Global Amlodipine and Olmesartan Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Amlodipine and Olmesartan Production Site of Key Manufacturer
Table 52. Amlodipine and Olmesartan New Entrant and Capacity Expansion Plans
Table 53. Amlodipine and Olmesartan Mergers & Acquisitions in the Past Five Years
Table 54. Global Amlodipine and Olmesartan Sales by Region (2017-2022) & (K Units)
Table 55. Global Amlodipine and Olmesartan Sales by Region (2023-2028) & (K Units)
Table 56. Global Amlodipine and Olmesartan Revenue by Region (2017-2022) & (USD Million)
Table 57. Global Amlodipine and Olmesartan Revenue by Region (2023-2028) & (USD Million)
Table 58. Global Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 59. Global Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 60. Global Amlodipine and Olmesartan Revenue by Type (2017-2022) & (USD Million)
Table 61. Global Amlodipine and Olmesartan Revenue by Type (2023-2028) & (USD Million)
Table 62. Global Amlodipine and Olmesartan Price by Type (2017-2022) & (USD/Unit)
Table 63. Global Amlodipine and Olmesartan Price by Type (2023-2028) & (USD/Unit)
Table 64. Global Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 65. Global Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 66. Global Amlodipine and Olmesartan Revenue by Application (2017-2022) & (USD Million)
Table 67. Global Amlodipine and Olmesartan Revenue by Application (2023-2028) & (USD Million)
Table 68. Global Amlodipine and Olmesartan Price by Application (2017-2022) & (USD/Unit)
Table 69. Global Amlodipine and Olmesartan Price by Application (2023-2028) & (USD/Unit)
Table 70. North America Amlodipine and Olmesartan Sales by Country (2017-2022) & (K Units)
Table 71. North America Amlodipine and Olmesartan Sales by Country (2023-2028) & (K Units)
Table 72. North America Amlodipine and Olmesartan Revenue by Country (2017-2022) & (USD Million)
Table 73. North America Amlodipine and Olmesartan Revenue by Country (2023-2028) & (USD Million)
Table 74. North America Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 75. North America Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 76. North America Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 77. North America Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 78. Europe Amlodipine and Olmesartan Sales by Country (2017-2022) & (K Units)
Table 79. Europe Amlodipine and Olmesartan Sales by Country (2023-2028) & (K Units)
Table 80. Europe Amlodipine and Olmesartan Revenue by Country (2017-2022) & (USD Million)
Table 81. Europe Amlodipine and Olmesartan Revenue by Country (2023-2028) & (USD Million)
Table 82. Europe Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 83. Europe Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 84. Europe Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 85. Europe Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 86. Asia-Pacific Amlodipine and Olmesartan Sales by Region (2017-2022) & (K Units)
Table 87. Asia-Pacific Amlodipine and Olmesartan Sales by Region (2023-2028) & (K Units)
Table 88. Asia-Pacific Amlodipine and Olmesartan Revenue by Region (2017-2022) & (USD Million)
Table 89. Asia-Pacific Amlodipine and Olmesartan Revenue by Region (2023-2028) & (USD Million)
Table 90. Asia-Pacific Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 91. Asia-Pacific Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 92. Asia-Pacific Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 93. Asia-Pacific Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 94. South America Amlodipine and Olmesartan Sales by Country (2017-2022) & (K Units)
Table 95. South America Amlodipine and Olmesartan Sales by Country (2023-2028) & (K Units)
Table 96. South America Amlodipine and Olmesartan Revenue by Country (2017-2022) & (USD Million)
Table 97. South America Amlodipine and Olmesartan Revenue by Country (2023-2028) & (USD Million)
Table 98. South America Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 99. South America Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 100. South America Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 101. South America Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 102. Middle East & Africa Amlodipine and Olmesartan Sales by Region (2017-2022) & (K Units)
Table 103. Middle East & Africa Amlodipine and Olmesartan Sales by Region (2023-2028) & (K Units)
Table 104. Middle East & Africa Amlodipine and Olmesartan Revenue by Region (2017-2022) & (USD Million)
Table 105. Middle East & Africa Amlodipine and Olmesartan Revenue by Region (2023-2028) & (USD Million)
Table 106. Middle East & Africa Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 107. Middle East & Africa Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 108. Middle East & Africa Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 109. Middle East & Africa Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 110. Amlodipine and Olmesartan Raw Material
Table 111. Key Manufacturers of Amlodipine and Olmesartan Raw Materials
Table 112. Direct Channel Pros & Cons
Table 113. Indirect Channel Pros & Cons
Table 114. Amlodipine and Olmesartan Typical Distributors
Table 115. Amlodipine and Olmesartan Typical Customers
List of Figures
Figure 1. Amlodipine and Olmesartan Picture
Figure 2. Global Amlodipine and Olmesartan Revenue Market Share by Type in 2021
Figure 3. 5/20 mg Tablets
Figure 4. 10/20 mg Tablets
Figure 5. 5/40 mg Tablets
Figure 6. 10/40 mg Tablets
Figure 7. Global Amlodipine and Olmesartan Revenue Market Share by Application in 2021
Figure 8. Hospital
Figure 9. Drug store
Figure 10. Global Amlodipine and Olmesartan Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Amlodipine and Olmesartan Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Amlodipine and Olmesartan Sales (2017-2028) & (K Units)
Figure 13. Global Amlodipine and Olmesartan Price (2017-2028) & (USD/Unit)
Figure 14. Global Amlodipine and Olmesartan Production Capacity (2017-2028) & (K Units)
Figure 15. Global Amlodipine and Olmesartan Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Amlodipine and Olmesartan Market Drivers
Figure 17. Amlodipine and Olmesartan Market Restraints
Figure 18. Amlodipine and Olmesartan Market Trends
Figure 19. Global Amlodipine and Olmesartan Sales Market Share by Manufacturer in 2021
Figure 20. Global Amlodipine and Olmesartan Revenue Market Share by Manufacturer in 2021
Figure 21. Amlodipine and Olmesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Amlodipine and Olmesartan Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Amlodipine and Olmesartan Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Amlodipine and Olmesartan Sales Market Share by Region (2017-2028)
Figure 25. Global Amlodipine and Olmesartan Revenue Market Share by Region (2017-2028)
Figure 26. North America Amlodipine and Olmesartan Revenue (2017-2028) & (USD Million)
Figure 27. Europe Amlodipine and Olmesartan Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Amlodipine and Olmesartan Revenue (2017-2028) & (USD Million)
Figure 29. South America Amlodipine and Olmesartan Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Amlodipine and Olmesartan Revenue (2017-2028) & (USD Million)
Figure 31. Global Amlodipine and Olmesartan Sales Market Share by Type (2017-2028)
Figure 32. Global Amlodipine and Olmesartan Revenue Market Share by Type (2017-2028)
Figure 33. Global Amlodipine and Olmesartan Price by Type (2017-2028) & (USD/Unit)
Figure 34. Global Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
Figure 35. Global Amlodipine and Olmesartan Revenue Market Share by Application (2017-2028)
Figure 36. Global Amlodipine and Olmesartan Price by Application (2017-2028) & (USD/Unit)
Figure 37. North America Amlodipine and Olmesartan Sales Market Share by Type (2017-2028)
Figure 38. North America Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
Figure 39. North America Amlodipine and Olmesartan Sales Market Share by Country (2017-2028)
Figure 40. North America Amlodipine and Olmesartan Revenue Market Share by Country (2017-2028)
Figure 41. United States Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Amlodipine and Olmesartan Sales Market Share by Type (2017-2028)
Figure 45. Europe Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
Figure 46. Europe Amlodipine and Olmesartan Sales Market Share by Country (2017-2028)
Figure 47. Europe Amlodipine and Olmesartan Revenue Market Share by Country (2017-2028)
Figure 48. Germany Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Amlodipine and Olmesartan Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Amlodipine and Olmesartan Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Amlodipine and Olmesartan Revenue Market Share by Region (2017-2028)
Figure 57. China Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Amlodipine and Olmesartan Sales Market Share by Type (2017-2028)
Figure 64. South America Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
Figure 65. South America Amlodipine and Olmesartan Sales Market Share by Country (2017-2028)
Figure 66. South America Amlodipine and Olmesartan Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Amlodipine and Olmesartan Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Amlodipine and Olmesartan Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Amlodipine and Olmesartan Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Amlodipine and Olmesartan Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Amlodipine and Olmesartan in 2021
Figure 78. Manufacturing Process Analysis of Amlodipine and Olmesartan
Figure 79. Amlodipine and Olmesartan Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のアムロジピン-アトルバスタチン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用容器閉鎖装置（CCS）市場2022年：市場規模予測（～2028年）
  • 世界のワクチン及び医薬品用ガラス瓶＆バイアル市場2022年：市場規模予測（～2028年）
  • 世界のジピン降圧医薬品市場2022年：市場規模予測（～2028年）
  • 医薬品及び賦形剤のグローバル市場展望 2023年-2029年：中性脂肪、マンニトール、ソルビトール、ショ糖、ブドウ糖、でんぷん、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19121 )"世界のアムロジピン＆オルメサルタン市場2022年：市場規模予測（～2028年）" (英文：Global Amlodipine and Olmesartan Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。